ID29843A - Sistem pemberian obat melalui mulut yang dikontrol secara teratur yang memberikan pengontrolan tempat dan bersifat sementara - Google Patents

Sistem pemberian obat melalui mulut yang dikontrol secara teratur yang memberikan pengontrolan tempat dan bersifat sementara

Info

Publication number
ID29843A
ID29843A IDW20010594A ID20010594A ID29843A ID 29843 A ID29843 A ID 29843A ID W20010594 A IDW20010594 A ID W20010594A ID 20010594 A ID20010594 A ID 20010594A ID 29843 A ID29843 A ID 29843A
Authority
ID
Indonesia
Prior art keywords
control
mouth
giving system
regular
drug giving
Prior art date
Application number
IDW20010594A
Other languages
English (en)
Inventor
Naresh Talwar
Sen Himadri
John H Staniforth
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/152,932 external-priority patent/US6261601B1/en
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of ID29843A publication Critical patent/ID29843A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Nutrition Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Physiology (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IDW20010594A 1998-09-14 1999-01-19 Sistem pemberian obat melalui mulut yang dikontrol secara teratur yang memberikan pengontrolan tempat dan bersifat sementara ID29843A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/152,932 US6261601B1 (en) 1997-09-19 1998-09-14 Orally administered controlled drug delivery system providing temporal and spatial control

Publications (1)

Publication Number Publication Date
ID29843A true ID29843A (id) 2001-10-18

Family

ID=22545063

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20010594A ID29843A (id) 1998-09-14 1999-01-19 Sistem pemberian obat melalui mulut yang dikontrol secara teratur yang memberikan pengontrolan tempat dan bersifat sementara

Country Status (41)

Country Link
EP (2) EP1107741B1 (id)
JP (1) JP2002524494A (id)
CN (1) CN1186013C (id)
AP (1) AP1659A (id)
AR (1) AR022672A1 (id)
AT (1) ATE245414T1 (id)
AU (1) AU758324B2 (id)
BG (1) BG105339A (id)
BR (1) BR9913696A (id)
CA (1) CA2343760A1 (id)
CO (1) CO5130022A1 (id)
CU (1) CU23040A3 (id)
CZ (1) CZ2001901A3 (id)
DE (1) DE69909801T2 (id)
DK (1) DK1107741T3 (id)
EA (2) EA004443B1 (id)
EE (1) EE200100153A (id)
ES (1) ES2204098T3 (id)
GE (1) GEP20043216B (id)
HK (1) HK1037967A1 (id)
HR (1) HRP20010187B1 (id)
HU (1) HUP0103632A3 (id)
ID (1) ID29843A (id)
IL (1) IL141977A0 (id)
IS (1) IS5885A (id)
MX (1) MXPA01002634A (id)
MY (1) MY127952A (id)
NO (1) NO20011276L (id)
NZ (2) NZ510487A (id)
OA (1) OA11652A (id)
PE (1) PE20001058A1 (id)
PL (1) PL346798A1 (id)
PT (1) PT1107741E (id)
SI (1) SI1107741T1 (id)
SK (1) SK285478B6 (id)
SV (1) SV1999000152A (id)
TR (1) TR200100731T2 (id)
UA (1) UA73287C2 (id)
UY (1) UY25710A1 (id)
WO (1) WO2000015198A1 (id)
ZA (1) ZA995839B (id)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001064183A1 (en) * 2000-03-03 2001-09-07 Ranbaxy Laboratories Limited Orally administered controlled delivery system for once daily administration of ciprofloxacin
DE10031043A1 (de) 2000-06-26 2002-02-14 Bayer Ag Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung
AU2006202275A1 (en) * 2000-06-26 2006-06-22 Bayer Healthcare Ag Sustained-release preparations of quinolone antibiotics and method for preparation thereof
CA2417764C (en) 2000-08-08 2009-05-05 Katsuo Kataoka Highly absorbable solid preparations containing sitafloxacin and tartaric acid
IN192748B (id) * 2000-08-29 2004-05-15 Ranbaxy Lab Ltd
JP2004513975A (ja) * 2000-12-05 2004-05-13 マクグレゴール　アレキサンダー 作用物質の制御放出のための静水圧デリバリシステム
KR20040018394A (ko) * 2001-07-04 2004-03-03 썬 파마슈티컬 인더스트리스 리미티드 위 정체 제어되는 약물 전달 계
JP2005501097A (ja) * 2001-08-16 2005-01-13 ザ ステイト オブ オレゴン アクティング バイ アンド スルー ザ ステイト ボード オブ ハイアー エデュケイション、 オン ビハーフ オブ オレゴン ステイト ユニバーシティー 膨張可能な胃内滞留装置
US6673369B2 (en) * 2001-08-29 2004-01-06 Ranbaxy Laboratories Limited Controlled release formulation
WO2003037296A2 (en) * 2001-10-29 2003-05-08 Labopharm Inc. Methods and dosage forms for improving the bioavailability of therapeutic agents
EP1443901A4 (en) * 2001-11-13 2010-06-16 Yamanouchi Pharma Tech Inc SYSTEM FOR THE DELAYED RELEASE OF SOLUBLE MEDICAMENTS
ES2259011T3 (es) * 2001-11-19 2006-09-16 Lupin Limited Composicion farmaceutica para la liberacion controlada de un antibiotico beta-lactama.
DE60219965T2 (de) * 2002-04-23 2008-01-17 Lupin Ltd., Mumbai Lang wirkende zusammensetzungen enthaltend zidovudine und/oder lamivudine
WO2005018613A1 (de) * 2003-08-26 2005-03-03 Mandapro Ag Pellets für die orale applikation von pharmazeutischen wirkstoffen
DE102004042139B4 (de) * 2004-08-31 2009-06-10 Aristocon Verwaltungs- Gmbh Perorale Darreichungsformen zur Erzielung eines Retardierungseffektes nach der Arzneimitteleinnahme mit einer Mahlzeit
GB0501810D0 (en) * 2005-01-28 2005-03-09 Pharmakodex Ltd Chemotherapeutic formulations
AU2006263338A1 (en) * 2005-06-29 2007-01-04 Panacea Biotec Ltd. Pharmaceutical sustained release compositions and processes thereof
EP1745775B1 (en) * 2005-07-19 2008-05-28 Ethypharm Gastroretentive formulations and manufacturing process thereof.
GB0515492D0 (en) * 2005-07-28 2005-08-31 Reckitt Benckiser Healthcare Improvements in or relating to compositions,articles and methods
KR20080076382A (ko) * 2007-02-15 2008-08-20 (주)아모레퍼시픽 실로스타졸의 제어방출 제제 및 그 제조방법
ZA200903854B (en) * 2008-06-19 2011-02-23 Univ Of The Witwatesrand Johannesburg A gastroretentive pharmaceutical dosage form
EP2329810A4 (en) 2008-08-18 2012-09-19 Team Academy Of Pharmaceutical Science DRUG DISPENSING SYSTEM WITH MAGNETIC RETENTION, MANUFACTURING PROCESS AND APPLICATION
WO2011125075A2 (en) 2010-04-08 2011-10-13 Fdc Limited A novel gastroretentive delivery of macrolide
EP2415460A1 (de) * 2010-08-03 2012-02-08 ratiopharm GmbH Orale Darreichungsform von Pregabalin
TWI705814B (zh) * 2014-06-20 2020-10-01 美商梅琳塔有限責任公司 醫藥組成物及其用途
US11504324B2 (en) 2014-11-19 2022-11-22 DuPont Nutrition USA, Inc. Nanosuspension formulation
US10987311B2 (en) 2017-06-16 2021-04-27 Kashiv Specialty Pharmaceuticals, Llc Extended release compositions comprising pyridostigmine
US10588863B2 (en) 2017-06-16 2020-03-17 Kashiv Biosciences, Llc Extended release compositions comprising pyridostigmine
WO2018232413A1 (en) 2017-06-16 2018-12-20 Kashiv Pharma Llc Gastroretentive dosage forms for sustained drug delivery
JP7048770B2 (ja) 2018-06-18 2022-04-05 アムニール コンプレックス プロダクツ リサーチ エルエルシー ピリドスチグミンを含む持続放出組成物
JP7034343B2 (ja) 2018-06-27 2022-03-11 アムニール コンプレックス プロダクツ リサーチ エルエルシー 自己調節性の浸透性胃保持性薬物送達システム
CN110448535A (zh) * 2019-09-04 2019-11-15 湖南宇山玉月农业科技有限公司 一种裂褶菌素胃漂浮片
CN111116794A (zh) * 2019-12-20 2020-05-08 蚌埠市鑫晟新材料科技有限公司 一种中性造纸用聚合材料的制备方法
CN115715765A (zh) * 2021-08-24 2023-02-28 江苏万邦生化医药集团有限责任公司 一种悬浮片剂
CN113768898A (zh) * 2021-09-14 2021-12-10 江苏万邦生化医药集团有限责任公司 悬浮的胶囊片

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0798742B2 (ja) * 1986-07-03 1995-10-25 ゼリア新薬工業株式会社 徐放性製剤組成物
US5096714A (en) * 1988-06-28 1992-03-17 Hauser-Kuhrts, Inc. Prolonged release drug tablet formulations
JPH0624959A (ja) * 1991-10-04 1994-02-01 Bayer Yakuhin Kk 胃内浮遊型薬物徐放性固形製剤

Also Published As

Publication number Publication date
OA11652A (en) 2004-12-08
CO5130022A1 (es) 2002-02-27
IS5885A (is) 2001-03-12
UA73287C2 (en) 2005-07-15
HK1037967A1 (en) 2002-03-01
PL346798A1 (en) 2002-02-25
TR200100731T2 (tr) 2001-06-21
DE69909801D1 (de) 2003-08-28
PE20001058A1 (es) 2000-10-05
EA004443B1 (ru) 2004-04-29
WO2000015198A1 (en) 2000-03-23
SI1107741T1 (en) 2004-02-29
EP1107741B1 (en) 2003-07-23
AU758324B2 (en) 2003-03-20
BG105339A (en) 2001-11-30
DK1107741T3 (da) 2003-11-17
UY25710A1 (es) 2000-03-31
NO20011276D0 (no) 2001-03-13
AP2001002098A0 (en) 2001-03-31
SK3472001A3 (en) 2001-10-08
JP2002524494A (ja) 2002-08-06
EA200100346A1 (ru) 2001-10-22
SV1999000152A (es) 2000-07-03
PT1107741E (pt) 2003-12-31
IL141977A0 (en) 2002-03-10
HRP20010187B1 (en) 2004-04-30
ATE245414T1 (de) 2003-08-15
ES2204098T3 (es) 2004-04-16
CN1325299A (zh) 2001-12-05
MXPA01002634A (es) 2002-06-04
AP1659A (en) 2006-09-06
NZ523747A (en) 2004-04-30
CN1186013C (zh) 2005-01-26
HUP0103632A3 (en) 2005-06-28
HUP0103632A2 (hu) 2002-02-28
EP1107741A1 (en) 2001-06-20
MY127952A (en) 2007-01-31
GEP20043216B (en) 2004-04-26
CU23040A3 (es) 2005-04-14
HRP20010187A2 (en) 2002-04-30
BR9913696A (pt) 2001-10-09
CA2343760A1 (en) 2000-03-23
SK285478B6 (sk) 2007-02-01
NZ510487A (en) 2003-04-29
EA200300847A1 (ru) 2003-12-25
ZA995839B (en) 2000-03-28
CZ2001901A3 (cs) 2001-08-15
AU1779499A (en) 2000-04-03
EP1281397A1 (en) 2003-02-05
EE200100153A (et) 2002-06-17
NO20011276L (no) 2001-05-10
AR022672A1 (es) 2002-09-04
DE69909801T2 (de) 2004-06-03
EA005767B1 (ru) 2005-06-30

Similar Documents

Publication Publication Date Title
ID29843A (id) Sistem pemberian obat melalui mulut yang dikontrol secara teratur yang memberikan pengontrolan tempat dan bersifat sementara
ID26331A (id) Metode dan sistem untuk pita-pita kelipatan penarik
DE69732806D1 (de) Gesichts- und Atemschutzsystem
ID27821A (id) Sistem penghantaran obat yang dikontrol oleh tekanan/tenaga komputer dan sejenisnya
ID22721A (id) Sistem pendekodean dan pengenkodean yang hilang
ID18738A (id) Sistem membran afinitas dan metoda penggunaannya
EE200100055A (et) Hädakõne ja lühisõnumi süsteemi eripärad
ID27118A (id) Sistem dan metode pengaturan reservoir
DE69828963D1 (de) Wirstoffabgabe und gentherapiesystem
ID25768A (id) Metode dan sistem untuk melaksanakan pengolahan zat-zat butiran yang dilekati polutan
DE69935606D1 (de) Adjuvanzsysteme und impfstoffe
ID26773A (id) Sulfur tersubstitusi pada asam sulfonilaminokarboksilat n-arilamida, persiapan, penggunaan dan persiapan pembuatan obat yang menyertainya
ID30039A (id) Manik-manik baru farmasi pelepasan terkontrol metode pembuatannya dan formulasi berbagai unit yang mengandungnya
DE69934198D1 (de) Atmungs und bewegungs ueberwachungssystem
ID19672A (id) Sistem terpadu memonitor penggunaan material, mengatur dan memonitor pengiriman material dan memberikan surat tagihan material yang dikirim
EE03904B1 (et) Graanul, farmatseutiline doseerimisvorm, graanulite valmistamismeetod ja ravimiga kaetud graanulid
ID22792A (id) Pigmen titanium dioksida, penyiapan dan penggunaannya
DE69833948D1 (de) Aktives system zur frühen zerstörung von schleppwirbeln
ID16202A (id) Sistem pemesanan yang memberikan penjelajahan sleksifer dan metodanya
ID22927A (id) Penggunaan peralatan dalam sistem sumur
ID25807A (id) Peralatan pendeteksi aliran masuk dan sistem penggunaannya
ID22660A (id) Turunan-turunan piridina dan komposisi farmasi yang mengandungnya
ID28368A (id) Tanda-tanda mikrosatelite tumbuhan dan metode terhadap penggunaannya
ID20723A (id) Metoda dan sistem peregenerasian material fluoresen
ID29871A (id) Turunan-turunan morfolin baru, metode pembuatannya dan komposisi-komposisi farmasi yang mengandungnya